JPJohn Pendlebury

John Pendlebury

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John Pendlebury has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study

    by Adrian Heald, John Pendlebury, Simon Anderson, Vinesh Narayan, Mark Guy, Martin Gibson, Peter Haddad, Mark Livingston

    Cardiometabolic disease is more common in patients with schizophrenia than the general population. The purpose of the study was to assess lifestyle factors, including diet and exercise, in patients with schizophrenia and estimate the prevalence of metabolic syndrome. This is a cross-sectional study of a representative group of outpatients with schizophrenia in Salford, UK. An interview supplemented by questionnaires was used to assess diet, physical activity, and cigarette and alcohol use. Likert scales assessed subjects’ views of diet and activity. A physical examination and relevant blood tests were conducted. Thirty-seven people were included in the study. 92% of men had central adiposity, as did 91.7% of women (International Diabetes Federation Definition). The mean age was 46.2 years and mean illness duration was 11.6 years. 67.6% fulfilled criteria for the metabolic syndrome. The mean number of fruit and vegetable portions per day was 2.8 ± 1.8. Over a third did not eat any fruit in a typical week. 42% reported doing no vigorous activity in a typical week. 64.9% smoked and in many cigarette use was heavy. The Likert scale showed that a high proportion of patients had insight into their unhealthy lifestyles. Within this sample, there was a high prevalence of poor diet, smoking and inadequate exercise. Many did not follow national recommendations for dietary intake of fruit and vegetables and daily exercise. These factors probably contribute to the high prevalence of metabolic syndrome. Many had insight into their unhealthy lifestyles. Thus, there is potential for interventions to improve lifestyle factors and reduce the risk of cardiometabolic disease.


  • Open Access

    STEPWISE – STructured lifestyle Education for People WIth SchizophrEnia: a study protocol for a randomised controlled trial

    by Rebecca Gossage-Worrall, Richard I. G. Holt, Katharine Barnard, Marian E. Carey, Melanie J. Davies, Chris Dickens, Yvonne Doherty, Charlotte Edwardson, Paul French, Fiona Gaughran, et al.

    People with schizophrenia are two to three times more likely to be overweight than the general population. The UK National Institute of Health and Care Excellence (NICE) recommends an annual physical health review with signposting to, or provision of, a lifestyle programme to address weight concerns and obesity. The purpose of this randomised controlled trial is to assess whether a group-based structured education programme can help people with schizophrenia to lose weight. Design: a randomised controlled trial of a group-based structured education programme. Setting: 10 UK community mental health trusts. Participants: 396 adults with schizophrenia, schizoaffective, or first-episode psychosis who are prescribed antipsychotic medication will be recruited. Participants will be overweight, obese or be concerned about their weight. Intervention: participants will be randomised to either the intervention or treatment as usual (TAU). The intervention arm will receive TAU plus four 2.5-h weekly sessions of theory-based lifestyle structured group education, with maintenance contact every 2 weeks and ‘booster’ sessions every 3 months. All participants will receive standardised written information about healthy eating, physical activity, alcohol and smoking. Outcomes: the primary outcome is weight (kg) change at 1 year post randomisation. Secondary outcomes, which will be assessed at 3 and 12 months, include: the proportion of participants who maintained or reduced their weight; waist circumference; body mass index; objectively measured physical activity (wrist accelerometer); self-reported diet; blood pressure; fasting plasma glucose, lipid profile and HbA1c (baseline and 1 year only); health-related quality of life (EQ-5D-5L and RAND SF-36); (adapted) brief illness perception questionnaire; the Brief Psychiatric Rating Scale; the Client Service Receipt Inventory; medication use; smoking status; adverse events; depression symptoms (Patient Health Questionnaire-9); use of weight-loss programmes; and session feedback (intervention only). Outcome assessors will be blind to trial group allocation. Qualitative interviews with a subsample of facilitators and invention-arm participants will provide data on intervention feasibility and acceptability. Assessment of intervention fidelity will also be performed. The STEPWISE trial will provide evidence for the clinical and cost-effectiveness of a tailored intervention, which, if successful, could be implemented rapidly in the NHS. ISRCTN19447796 , registered on 20 March 2014.


  • Open Access

    Prolactin and Schizophrenia, an Evolving Relationship

    by Chris J., John Pendlebury

  • Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness

    by Richard I. G. Holt, John Pendlebury, Hiram J. Wildgust, Chris J. Bushe

    Obesity is 2 to 3 times more common among people with severe mental illness and has adverse effects on physical and psychological health. We report the experience from the first 8 years of a self-referring weight management clinic. From 2000 to 2008, 113 patients with severe mental illness (according to ICD-10 criteria) with a mean +/- SE age of 43.8 +/- 1.7 years (range, 22-71 years) referred themselves to this clinic. The patients were seen in weekly group sessions lasting 1 hour that involved weight measurement, discussion, and education. The response to the program was assessed by the paired Student t test and linear analysis corrected for repeated measures. Mean +/- SE baseline weight was 90.1 +/- 1.6 kg (body mass index [BMI] = 32.2 +/- 0.5 kg/m(2)). Fifty subjects of the 142 total patient episodes (35%) dropped out within the first 3 months. Sixty-four subjects completed 1 year of the program, and 35 have attended for 2 years or longer. There were progressive statistically significant reductions in mean weight and BMI throughout the duration of monitoring, with no suggestion of a plateau. The mean +/- SE final weight loss was 7.2 +/- 0.6 kg. Weight loss was correlated only with the number of sessions attended (r = 0.42, P < .0001). Lifestyle advice within a group setting may be effective in long-term management of obese and overweight patients with severe mental illness.


  • Long‐term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK

    by J. Pendlebury, C. J. Bushe, H. J. Wildgust, R. I. G. Holt

    Objective:  Obesity is common among people with severe mental illness (SMI). We report our experience from the first 4 years of The Cromwell House weight management clinic.Method:  Ninety‐three patients with SMI aged 43.7 ± 1.2 years referred themselves to this clinic. The patients were seen in weekly group sessions that involved weight measurement, discussion and education.Results:  Mean baseline weight was 89.5 ± 1.8 kg [body mass index (BMI) 32.3 ± 0.5 kg/m2]. Twenty‐three per cent dropped out within the first 8 weeks. There was progressive statistically significant reduction in mean weight and BMI throughout the duration of monitoring with no suggestion of a plateau. The mean final weight loss was 6.2 ± 0.6 kg. Weight loss was correlated only with the number of sessions attended (r = 0.53, P < 0.0001).Conclusion:  Long‐term weight management of obese and overweight patients with severe forms of mental illness was possible through the provision of simple lifestyle advice within the group setting.


  • Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results

    by John Pendlebury, Peter Haddad, Serdar Dursun

    Excess weight is a common problem in the general population and in those with severe mental illness and is associated with a range of adverse consequences. The evidence base for managing excess weight in those with severe psychiatric illness is small. We report the outcome of a weight management programme provided in a community mental health centre. The programme consisted of group sessions, held weekly and lasting one hour. Participants self‐referred and attended as many sessions as they wished. Sessions included weighing, feedback from participants and education on a range of issues including healthy eating and exercise. Over a 3‐year period 70 patients, predominantly with schizophrenia, attended the programme. Length of follow‐up ranged from 2 weeks to 3 years. Data for all 70 patients was evaluated. The mean BMI at entry to the programme was 32.5 kg/m2. The mean number of sessions attended was 34. Patients achieved a mean weight loss of 4.97 kg. The mean BMI at last attendance was 30.7 kg/m2. Weight loss correlated with number of sessions attended (p = 0.0001). This study demonstrates the long‐term value of a weight management programme at 3 years and supports the hypothesis that weight loss can be achieved using a simple behavioural intervention in motivated psychiatric patients. Copyright © 2005 John Wiley & Sons, Ltd.